![Roger Jeffs](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Roger Jeffs
Chief Executive Officer at
LIQUIDIA CORPORATION
Net worth: 151 M $ as of 2026-05-30
Profile
Roger A. Jeffs is the founder of Bull City Select Investments LLC, Kriya Therapeutics, Inc. Current positions include Chief Executive Officer & Director at Liquidia Corp.
since 2022, Independent Director at Axsome Therapeutics, Inc. since 2014, and Director at Albireo AB. Former roles include President, Co-Chief Executive Officer & Director at United Therapeutics Corp.
from 2015 to 2016, Associate Director-Clinical Research at Amgen, Inc. in 1998, Independent Director at Sangamo Therapeutics, Inc. from 2017 to 2019, Independent Director at Spyryx Biosciences, Inc., Director at Sio Gene Therapies, Inc. from 2018 to 2019, Independent Director at Dova Pharmaceuticals, Inc. from 2017 to 2019, Independent Director at Albireo Pharma, Inc. from 2017 to 2022, Director at Roivant Sciences, Inc. from 2018 to 2019, Director at Evecxia, Inc. from 2016 to 2021, Director at Liquidia PAH LLC from 2018 to 2020, and Member-Clinical Research at Glaxo Wellcome, Inc. in 1995.
Education includes an undergraduate degree from Duke University in 1984 and a doctorate from UNC School of Medicine in 1991.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-05-26 | 2,225,770 ( 2.5% ) | 138 M $ | 2026-05-30 | |
| 2026-06-10 | 58,367 ( 0.11% ) | 14 M $ | 2026-05-30 |
Roger Jeffs active positions
| Companies | Position | Start |
|---|---|---|
| AXSOME THERAPEUTICS, INC. | Director/Board Member | 2014-11-30 |
| LIQUIDIA CORPORATION | Chief Executive Officer | 2022-01-02 |
Kriya Therapeutics, Inc.
 Kriya Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company developing gene therapies for treatment of chronic diseases | Founder | 2018-12-31 |
Albireo AB
 Albireo AB Pharmaceuticals: MajorHealth Technology Develops bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal diseases and disorders | Director/Board Member | - |
Bull City Select Investments LLC
 Bull City Select Investments LLC Financial ConglomeratesFinance Provides investment services | Founder | - |
Former positions of Roger Jeffs
| Companies | Position | End |
|---|---|---|
| ALBIREO PHARMA, INC. | Director/Board Member | 2022-01-02 |
Evecxia, Inc.
 Evecxia, Inc. Pharmaceuticals: MajorHealth Technology Produces natural brain serotonin to treat mental illnesses | Director/Board Member | 2021-03-01 |
RareGen LLC
 RareGen LLC Miscellaneous Commercial ServicesCommercial Services Provides investment and commercialization for rare disease pharmaceutical products | Director/Board Member | 2020-10-31 |
| DOVA PHARMACEUTICALS, INC. | Director/Board Member | 2019-11-11 |
| ░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Roger Jeffs
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
73
1st degree connections
18
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 18 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
United Therapeutics Corp.
 United Therapeutics Corp. BiotechnologyHealth Technology Operates as a biotechnology company that develops and commercializes products to address the unmet medical needs of patients with chronic & life-threatening conditions | Health Technology |
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Axsome Therapeutics, Inc.
 Axsome Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures novel therapies for the management of central nervous system | Health Technology |
Spyryx Biosciences, Inc.
 Spyryx Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for obstructive lung diseases | Health Technology |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Glaxo Wellcome, Inc.
 Glaxo Wellcome, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical preparations | Health Technology |
Albireo AB
Albireo AB Pharmaceuticals: MajorHealth Technology Develops bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal diseases and disorders | Health Technology |
UNC School of Medicine
 UNC School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sio Gene Therapies, Inc.
 Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops gene therapies to treat neurodegenerative diseases | Health Technology |
Dova Pharmaceuticals, Inc.
 Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs with disorder of low blood platelet count | Health Technology |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders | Health Technology |
Bull City Select Investments LLC
Bull City Select Investments LLC Financial ConglomeratesFinance Provides investment services | Finance |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Health Technology |
Evecxia, Inc.
Evecxia, Inc. Pharmaceuticals: MajorHealth Technology Produces natural brain serotonin to treat mental illnesses | Health Technology |
Kriya Therapeutics, Inc.
Kriya Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company developing gene therapies for treatment of chronic diseases | Health Technology |
RareGen LLC
RareGen LLC Miscellaneous Commercial ServicesCommercial Services Provides investment and commercialization for rare disease pharmaceutical products | Commercial Services |
Liquidia Corp.
 Liquidia Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
- Stock Market
- Insiders
- Roger Jeffs
